Key statistics
On Monday, Recursion Pharmaceuticals Inc (RXRX:NSQ) closed at 3.63, 21.81% above the 52 week low of 2.98 set on Feb 18, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 3.48 |
|---|---|
| High | 3.71 |
| Low | 3.46 |
| Bid | 3.46 |
| Offer | 3.48 |
| Previous close | 3.67 |
| Average volume | 21.56m |
|---|---|
| Shares outstanding | 527.40m |
| Free float | 506.63m |
| P/E (TTM) | -- |
| Market cap | 1.91bn USD |
| EPS (TTM) | -1.48 USD |
Data delayed at least 15 minutes, as of Mar 02 2026 21:00 GMT.
More ▼
- Recursion Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
- Recursion To Be Featured in HighRes’ Lightning Talk at NVIDIA GTC
- Recursion to Participate in Upcoming Investor Conferences
- Recursion to Report Fourth Quarter and Full Year 2025 Business Updates and Financial Results on February 25
- Recursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules
- Recursion to Present at 44th Annual J.P. Morgan Healthcare Conference
- Positive Phase 1b/2 Results from Ongoing REC-4881 TUPELO Trial Demonstrate Rapid and Durable Reductions in Polyp Burden in Familial Adenomatous Polyposis (FAP) at 25 Weeks
- Recursion Announces Webinar For Upcoming Clinical Data Readout on the TUPELO Phase 1b/2 Trial of REC-4881 in Familial Adenomatous Polyposis on December 8, 2025
- Recursion Reports Third Quarter 2025 Financial Results and Provides Business Update
- Recursion Announces CEO Transition Plan to Drive Next Phase of Growth
More ▼
